RP-606 Rights Revert to Medivir
09 déc. 2005 03h09 HE
|
Medivir
HUDDINGE, Sweden, Dec. 9, 2005 (PRIMEZONE) -- Medivir announced today that all rights relating to the development of RP-606 (MIV-606), an oral antiviral being developed for the treatment of herpes...
Medivir: Advances in Chronic Obstructive Pulmonary Disease (COPD) Research Program
21 nov. 2005 03h38 HE
|
Medivir
HUDDINGE, Sweden, Nov. 21, 2005 (PRIMEZONE) -- Medivir (Huddinge, Sweden) and one of China's largest pharmaceutical companies, Jiangsu Hengrui Medicine Company (Shanghai), instigated a two year...
Medivir, Interim Report, 1 January - 30 September 2005
26 oct. 2005 08h24 HE
|
Medivir
HUDDINGE, Sweden, Oct. 26, 2005 (PRIMEZONE) -- Medivir, Interim Report, 1 January -- 30 September 2005
-- A phase IIa study on MIV-210 against multiresistant HIV began in September.
-- A...
Medivir Financial Statement, 1 January -- 31 December 2004
18 févr. 2005 08h03 HE
|
Medivir
HUDDINGE, Sweden, Feb. 18, 2005 (PRIMEZONE) -- Medivir's new issue was fully subscribed in June, raising the company SEK 322.5 m before deducting issue costs.
- In July, Medivir and Biovitrum...
GSK Terminates MIV-210 Partnership -- Medivir to Initiate Phase II Trial
27 déc. 2004 02h50 HE
|
Medivir
HUDDINGE, Sweden, Dec. 27, 2004 (PRIMEZONE) -- Medivir AB announced today that GlaxoSmithKline (GSK) has terminated the research agreement for the developmental HIV compound MIV-210, as the compound...
Medivir AB enters into License and Research Collaboration Agreement on Hepatitis C
30 nov. 2004 02h56 HE
|
Medivir
HUDDINGE, Sweden, Nov. 30, 2004 (PRIMEZONE) -- Medivir AB today announced that it has signed a license and research collaboration agreement on Hepatitis C with Tibotec Pharmaceuticals Ltd, a...
Medivir Interim Report, 1 January -- 30 September 2004
26 oct. 2004 07h51 HE
|
Medivir
HUDDINGE, Sweden, Oct. 26, 2004 (PRIMEZONE) -- Medivir:
- In August, Medivir and Novartis resolved the partly overlapping patent issue on ME-609 (herpes) in the U.S.
- The collaboration between...
Medivir and Novartis Resolve Issue of Partly Overlapping Patents in USA
13 août 2004 03h18 HE
|
Medivir
HUDDINGE, Sweden, Aug. 13, 2004 (PRIMEZONE) -- Medivir and Novartis have resolved the issue of partly overlapping patents in the USA relating to the Medivir ME-609 project by means of a free, two-way...
Medivir & Biovitrum Initiate Research Collaboration in Diabetes
16 juil. 2004 07h03 HE
|
Medivir
HUDDINGE, Sweden, July 16, 2004 (PRIMEZONE) -- Medivir and Biovitrum today announce that they initiate a research collaboration to meet the significant and growing medical need in type 2...
Medivir Interim Report 1 Jan. -- 30 June 2004
06 juil. 2004 05h36 HE
|
Medivir
HUDDINGE, Sweden, July 06, 2004 (PRIMEZONE) -- Medivir's new share issue was fully subscribed in June, whereby the company raised SEK 322.5 m before deducting issue costs.
. A CD (candidate drug)...